Latest California Healthline Stories
Government officials want to focus on fighting COVID-19 instead of recouping overcharges that run into the millions.
One woman’s experience with the high cost of dental care and confusing Medicare coverage offers a teachable moment for other consumers. Her small church took up a collection, but the surprise bill — four times what she expected to pay — was sent to collections.
A lawsuit against Group Health surfaces as the White House promotes Medicare Advantage for seniors.
For more than a decade, customers used the online plan finder to compare dozens of policies. Yet after a redesign of the website, the search results no longer list which plan offers a customer the best value. Federal officials say it will be fixed before enrollment begins next week.
The president’s outline of key health policy concerns touched on a variety of hot-button issues from drug prices to immigration.
President Donald Trump, dogged by an impeachment inquiry, tries to change the subject by unveiling an executive order aimed at expanding the role of private Medicare health plans. The Trump administration also launched an effort this week to expand “wellness” programs aimed at getting people with insurance to practice better health habits – even though research has shown the efforts don’t generally improve health or save money. This week, Alice Miranda Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more.
The Freedom of Information Act lawsuit could spur the Centers for Medicare & Medicaid Services to release audits that document up to $650 million in overcharges.
Amid an overall crackdown on private insurers’ Medicare billing practices, a new government audit and a whistleblower suit allege St. Louis-based Essence Group Holdings Corp.’s Medicare Advantage plans overcharged taxpayers.
An enhanced government effort to catch insurers that overcharge Medicare faces resistance from the insurance industry.
The problem affects private drug policies and Medicare Advantage plans that provide both medical and drug coverage and substitute for traditional government-run Medicare. It could leave plan members without coverage.